Brian Lorig - 30 Jun 2025 Form 4 Insider Report for KLA CORP (KLAC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Jul 2025, 16:05:06 UTC
Prior SEC filing
09 Aug 2024
Next SEC filing
05 Aug 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jeffrey S. Cannon, as attorney-in-fact for Brian Lorig

Key filing fact

Brian Lorig filed Form 4 for KLA CORP (KLAC) on 02 Jul 2025.

Key facts

  • This page summarizes Brian Lorig's Form 4 filing for KLA CORP (KLAC).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Jul 2025, 16:05.

Change

  • Previous filing in this sequence was filed on 09 Aug 2024.
  • Current net transaction value: -$914,960.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001697041 Primary reporting owner

Lorig Brian

Relationship
EVP, KLA Global Services
Address
ONE TECHNOLOGY DRIVE, MILPITAS
Signature
/s/ Jeffrey S. Cannon, as attorney-in-fact for Brian Lorig
Signature date
02 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KLAC transaction

Common Stock

Other

Transaction value
$21,250
Shares
+39
Change %
+0.27%
Price
$541.13
Shares after
14,703
Date
30 Jun 2025
Ownership
Direct
Footnotes
F1, F2, F3
KLAC transaction

Common Stock

Tax liability

Transaction value
$936,210
Shares
-1,052
Change %
-7.2%
Price
$889.87
Shares after
13,651
Date
30 Jun 2025
Ownership
Direct
Footnotes
F4, F5, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Purchased under the registrant's employee stock purchase plan.

Footnote F2

Represents 85% of the closing price of the registrant's common stock on January 2, 2025, the first day of the offering period under the employee stock purchase plan.

Footnote F3

The number of shares of KLA common stock includes 10,657.955 shares issuable upon vesting of restricted stock units ("RSUs").

Footnote F4

On August 4, 2022, the reporting person was granted RSUs with both performance-based and service-based vesting conditions ("PRSUs") divided into three tranches. The first tranche was for a target number of shares equal to 1,678.000 shares of KLA common stock. The maximum number of shares issuable under the first tranche of these PRSUs is 250% of the target shares if the sum of KLA's non-GAAP earnings per diluted share for fiscal year 2023 and fiscal year 2024 equaled or exceeded $56.62. On August 1, 2024, KLA's Board of Directors and Compensation and Talent Committee determined that the performance conditions applicable to the first tranche of these PRSUs were satisfied at 131% of target shares. The first tranche of these PRSUs (2,198.180) vested on June 30, 2025, and were subject to the continued service of the reporting person.

Footnote F5

Pursuant to the terms of the grant, shares of KLA common stock were automatically withheld to cover required tax withholding on the 2,198.180 shares of KLA common stock that vested. The fair market value of KLA common stock used for purposes of calculating the number of shares to be withheld was the closing price of KLA common stock as reported on June 30, 2025.

Footnote F6

The number of shares of KLA common stock includes 8,459.775 shares issuable upon vesting of RSUs.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .